Home
>
National Drug Code (NDC)
>
Ranitidine
Ranitidine - 55390-618-01 - (Ranitidine)
Drug Information of Ranitidine
| Product NDC: | 55390-618 |
| Proprietary Name: | Ranitidine |
| Non Proprietary Name: | Ranitidine |
| Active Ingredient(s): | 25 mg/mL & nbsp; Ranitidine |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ranitidine
| Product NDC: | 55390-618 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077458 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060329 |
Package Information of Ranitidine
| Package NDC: | 55390-618-01 |
| Package Description: | 1 VIAL in 1 BOX (55390-618-01) > 40 mL in 1 VIAL |
NDC Information of Ranitidine
| NDC Code | 55390-618-01 |
| Proprietary Name | Ranitidine |
| Package Description | 1 VIAL in 1 BOX (55390-618-01) > 40 mL in 1 VIAL |
| Product NDC | 55390-618 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ranitidine |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20060329 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | RANITIDINE HYDROCHLORIDE |
| Strength Number | 25 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |
